FDA grants EUA for Thermo Fisher Scientific’s Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit. Credit: Thermo Fisher Scientific Inc.

Thermo Fisher Scientific has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its multiplex real-time PCR test, Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit.

The kit is used for identifying and distinguishing RNA from the SARS-CoV2, and influenza A and B viruses in nasopharyngeal and nasal swabs.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Thermo Fisher Scientific Genetic Sciences president Mark Smedley said: “Understanding that the flu season would overlap with surges in Covid-19 infections, Thermo Fisher worked rapidly to develop a new multiplex real-time PCR diagnostic kit for detecting and differentiating SARS-CoV-2, influenza A, and influenza B.

“These are illnesses, which can present with similar clinical symptoms, but for which patient management, including quarantining measures, greatly differs.

“This new kit offers clinical and public health laboratories a single test to help diagnose and monitor the spread of Covid-19 and the flu.”

Apart from aiding laboratories in increasing their present Covid-19 testing menu for respiratory samples, the kit will help maintain low operational costs and simple workflow.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the TaqPath COVID-19, Flu A, Flu B Combo Kit includes Applied Biosystems Pathogen Interpretive Software for automatically converting genetic analysis data into a readable report. This will lower the chances of user interpretation error.

Thermo Fisher noted that testing with the kit is limited to Clinical Laboratory Improvement Amendments of 1988 (CLIA) certified laboratories for carrying out high-complexity tests or by non-US labs with similar qualifications.

Last December, the company introduced a new direct-from-saliva PCR test for Covid-19 to support extensive, high-frequency surveillance testing.

The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples to streamline lab workflows with the help of tools available worldwide to provide reliable data rapidly.